Matches in Nanopublications for { ?s ?p "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1235337.RAR02CzR4P4CrhQ3ohhAyTJZcBNUB49DTaCuzC8F7o4kY130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235337.RAR02CzR4P4CrhQ3ohhAyTJZcBNUB49DTaCuzC8F7o4kY130_provenance.
- NP1235338.RAVzKNTFMCworHxYGCbIqLR1VS_YX9v1Cp_BtBjLX6HwI130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235338.RAVzKNTFMCworHxYGCbIqLR1VS_YX9v1Cp_BtBjLX6HwI130_provenance.
- NP1235344.RAn2PjummCzlNzuT_1gtpjV5fZpjWiIrFJF1v2MGQINpo130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235344.RAn2PjummCzlNzuT_1gtpjV5fZpjWiIrFJF1v2MGQINpo130_provenance.
- NP1235345.RAo6h5LPkrKX304FizyQPor-TD7MQq595aHCG6mXp2aq4130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235345.RAo6h5LPkrKX304FizyQPor-TD7MQq595aHCG6mXp2aq4130_provenance.
- NP1235346.RAqevmM0pynvRIih5-MZbH5D8X-NjEPxmGVTB_iJsiR-s130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235346.RAqevmM0pynvRIih5-MZbH5D8X-NjEPxmGVTB_iJsiR-s130_provenance.
- NP1235340.RAGnYkFmNGWDxmBE1x-cHa0A2eF0CUN5ruH8ZJ9USDqoI130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235340.RAGnYkFmNGWDxmBE1x-cHa0A2eF0CUN5ruH8ZJ9USDqoI130_provenance.
- NP1235347.RANarJz-UM7qKSRMpEH7buWOqrq0iLSMb4-SpHoUI4Nzk130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235347.RANarJz-UM7qKSRMpEH7buWOqrq0iLSMb4-SpHoUI4Nzk130_provenance.
- NP1235343.RAypizHlQKNJgq6qdjZcnI4QyjFrIODX-O9hpUyLuMTDI130_assertion description "[Moreover, EMSA and ChIP assays demonstrated that the allele A disrupts the binding site of ETS-1, thus markedly decreases the activity of the TBX22 promoter, which is likely to lead to the birth defect of the CPO without ankyloglossia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1235343.RAypizHlQKNJgq6qdjZcnI4QyjFrIODX-O9hpUyLuMTDI130_provenance.